In a state of hepatic IR, in which insulin-mediated activation of glycogen synthase is impaired, dietary glucose moieties will be redirected into the de novo lipogenesis pathway thereby further promoting lipid accumulation in NAFLD (1). Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.